Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Epizyme Inc
(NQ:
EPZM
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 11, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.460 (51)
Ask (Size)
1.470 (263)
Prev. Close
1.470
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
168,364,752
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Epizyme: Q2 Earnings Insights
August 09, 2022
Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
August 09, 2022
From
Epizyme, Inc.
Via
Business Wire
Performance
More News
Read More
EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM
July 12, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM
June 27, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Is Epizyme (EPZM) Stock Up 75% Today?
June 27, 2022
Via
InvestorPlace
Why Epizyme Shares Are Soaring Today
June 27, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022
June 28, 2022
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Via
Benzinga
Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027
June 28, 2022
Via
FinancialNewsMedia
Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
June 27, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022
June 27, 2022
Via
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Via
Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
Via
Benzinga
EPZM Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Epizyme, Inc. Is Fair to Shareholders
June 27, 2022
From
Halper Sadeh LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 27, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 27, 2022
Via
InvestorPlace
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
June 27, 2022
Via
Benzinga
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
June 27, 2022
Via
Benzinga
Ipsen to acquire Epizyme, expanding its portfolio in oncology
June 27, 2022
From
Epizyme, Inc.
Via
Business Wire
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
June 14, 2022
Via
Benzinga
93 Biggest Movers From Yesterday
June 14, 2022
Via
Benzinga
91 Biggest Movers From Friday
June 13, 2022
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.